At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 70 enrolled
Drug / intervention
AIJP (Arnebia Indigo Jade Pearl) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Phase II Study for Treatment of Anal HSIL Through Use of a Chinese Herbal Topical Cream
In Brief
A Phase 2 clinical trial evaluating AIJP (Arnebia Indigo Jade Pearl) and Placebo for Anus Neoplasms. Completed, enrolled 70 participants across 1 site.
Detailed Summary
The purpose of this study is to find out if a Chinese herbal cream is effective in treating HSIL (high-grade squamous intraepithelial lesions, also known as HGAIN, or high-grade anal intraepithelial neoplasia).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnus Neoplasms
CountriesUnited States
CollaboratorsSpring Wind Herbs
Timeline
Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 2008
Enrollment StartMay 2008
Primary CompletionDec 2012
TodayJul 2026
First PostedFeb 25, 2008
Enrollment StartMay 14, 2008
Primary CompletionDec 12, 2012
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 18.4 years ago
Interventions
AIJP (Arnebia Indigo Jade Pearl)drug
Participants will administer their own treatment using 1/4 teaspoon of the cream twice daily for 48 weeks.
Placebodrug
Placebo twice daily for 48 weeks.